207 related articles for article (PubMed ID: 25059388)
1. The proteomics of pediatric brain tumors.
Anagnostopoulos AK; Tsangaris GT
Expert Rev Proteomics; 2014 Oct; 11(5):641-8. PubMed ID: 25059388
[TBL] [Abstract][Full Text] [Related]
2. Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study.
Martelli C; Iavarone F; D'Angelo L; Arba M; Vincenzoni F; Inserra I; Delfino D; Rossetti DV; Caretto M; Massimi L; Tamburrini G; Di Rocco C; Caldarelli M; Messana I; Castagnola M; Sanna MT; Desiderio C
Mol Biosyst; 2015 Jun; 11(6):1668-83. PubMed ID: 25909245
[TBL] [Abstract][Full Text] [Related]
3. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic histopathology, cytogenetics, and molecular markers of pediatric brain tumors.
Schofield DE
Neurosurg Clin N Am; 1992 Oct; 3(4):723-38. PubMed ID: 1327339
[TBL] [Abstract][Full Text] [Related]
5. The ongoing evolution of proteomics in malignancy.
Dhamoon AS; Kohn EC; Azad NS
Drug Discov Today; 2007 Sep; 12(17-18):700-8. PubMed ID: 17826682
[TBL] [Abstract][Full Text] [Related]
6. Cancer proteomics.
Tan HT; Lee YH; Chung MC
Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
[TBL] [Abstract][Full Text] [Related]
7. Pediatric brain tumors: Update of proteome-based studies.
Tsangaris GT; Anagnostopoulos AK
J Proteomics; 2018 Sep; 188():41-45. PubMed ID: 29471057
[TBL] [Abstract][Full Text] [Related]
8. Histology and molecular pathology of pediatric brain tumors.
Pfister S; Hartmann C; Korshunov A
J Child Neurol; 2009 Nov; 24(11):1375-86. PubMed ID: 19841426
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
10. Proteomics studies of childhood pilocytic astrocytoma.
Anagnostopoulos AK; Dimas KS; Papathanassiou C; Braoudaki M; Anastasiadou E; Vougas K; Karamolegou K; Kontos H; Prodromou N; Tzortzatou-Stathopoulou F; Tsangaris GT
J Proteome Res; 2011 May; 10(5):2555-65. PubMed ID: 21466243
[TBL] [Abstract][Full Text] [Related]
11. Circulating biomarker panels for targeted therapy in brain tumors.
Tanase C; Albulescu R; Codrici E; Popescu ID; Mihai S; Enciu AM; Cruceru ML; Popa AC; Neagu AI; Necula LG; Mambet C; Neagu M
Future Oncol; 2015; 11(3):511-24. PubMed ID: 25241806
[TBL] [Abstract][Full Text] [Related]
12. Proteomics: present and future implications in neuro-oncology.
Micallef J; Gajadhar A; Wiley J; DeSouza LV; Michael Siu KW; Guha A
Neurosurgery; 2008 Mar; 62(3):539-55; discussion 539-55. PubMed ID: 18425004
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
[TBL] [Abstract][Full Text] [Related]
14. Pediatric brain tumors.
Brandão LA; Poussaint TY
Neuroimaging Clin N Am; 2013 Aug; 23(3):499-525. PubMed ID: 23928202
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
de Bont JM; den Boer ML; Kros JM; Passier MM; Reddingius RE; Smitt PA; Luider TM; Pieters R
J Neuropathol Exp Neurol; 2007 Jun; 66(6):505-16. PubMed ID: 17549010
[TBL] [Abstract][Full Text] [Related]
16. Towards developing biomarkers for glioblastoma multiforme: a proteomics view.
Jayaram S; Gupta MK; Polisetty RV; Cho WC; Sirdeshmukh R
Expert Rev Proteomics; 2014 Oct; 11(5):621-39. PubMed ID: 25115191
[TBL] [Abstract][Full Text] [Related]
17. [A study group on brain tumors in childhood. Introduction, establishment and aims].
Kühl J
Klin Padiatr; 1987; 199(3):196-9. PubMed ID: 3626420
[TBL] [Abstract][Full Text] [Related]
18. Current and evolving knowledge of prognostic factors for pediatric ependymomas.
Andreiuolo F; Ferreira C; Puget S; Grill J
Future Oncol; 2013 Feb; 9(2):183-91. PubMed ID: 23414469
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Ependymoma: A Proteomics Perspective.
Tsangaris GT; Papathanasiou C; Adamopoulos PG; Scorilas A; Vorgias CE; Prodromou N; Stathopoulou FT; Stravopodis DJ; Anagnostopoulos AK
Cancer Genomics Proteomics; 2017; 14(2):127-136. PubMed ID: 28387652
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Mirian C; Thastrup M; Mathiasen R; Schmiegelow K; Olsen JV; Østergaard O
Fluids Barriers CNS; 2024 Feb; 21(1):14. PubMed ID: 38350915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
